Why is Natco Pharma falling/rising?

As of 15-Jul, Natco Pharma Ltd. is experiencing a price increase, currently at 1,010.90, reflecting a rise of 34.1 or 3.49%. The stock has shown positive performance recently, outperforming its sector by 2.24% today and achieving a consecutive gain over the last two days with a total return of 5.11%. Despite a year-to-date decline of 27.12%, the stock has performed well in the short term, with a 10.27% increase over the past month. The stock is currently trading above its 5-day, 20-day, 50-day, and 100-day moving averages, although it remains below the 200-day moving average. However, there has been a notable decrease in investor participation, with delivery volume falling by 49.22% compared to the 5-day average.
In the broader market context, Natco Pharma's short-term performance contrasts with the Sensex, which has declined by 1.36% over the past week. The company's strong fundamentals, including a high return on equity (ROE) of 15.57% and a low debt-to-equity ratio, contribute to its attractive valuation, as it trades at a discount compared to peers. Additionally, the company has demonstrated healthy long-term growth with an annual operating profit increase of 32.35%. The presence of high institutional holdings at 23.15% indicates confidence from investors with substantial resources to analyze the company's fundamentals, further supporting the stock's recent upward movement.